X. Long Zheng, M.D., Ph.D./LinkedIn
Oct 6, 2025, 12:00
X. Long Zheng: KU Medical Center Has Become A Destination For Research And Treatment Of TTP
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, posted on LinkedIn:
”In their Blood, KU Medical Center has become a destination for research and treatment of thrombotic thrombocytopenic purpura – or TTP – a rare and potentially deadly blood disorder. See more details here.”
Keep up with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together